Skip to main content
Clinical Trials/IRCT20230407057838N1
IRCT20230407057838N1
Completed
Phase 2

Comparison of the therapeutic effect of vaginal bromocriptine and dienogest on ultrasound and bleeding and pain due to adenomyosis

Iran University of Medical Sciences0 sites60 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
Iran University of Medical Sciences
Enrollment
60
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
Female

Investigators

Eligibility Criteria

Inclusion Criteria

  • History of 6 months of painful and regular menstruation

Exclusion Criteria

  • having a history of specific diseases (including epilepsy, gastrointestinal, cardiovascular, renal disorders) according to the person's own statement.
  • allergies to dienogest and bromocriptine
  • Presence of significant gynecological disease or abdominal and pelvic surgery in the last 6 months
  • \- Not using gonadotropin agonist or antagonist, hormonal contraceptive in the last three months.

Outcomes

Primary Outcomes

Not specified

Similar Trials